Stifel analysts, led by Brad Reback, have maintained their Buy rating on Microsoft Corporation (NASDAQ:MSFT), with a steady ...
Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...
Chevy's Trax is easily one of the best affordable cars GM has ever made and one of the best bargains available today. It ...